Position in HLN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$8,929,938
+$967,955 QoQ
Shares Held
957,121
+20.3% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 639 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $152,241,305 across 13 Drug Manufacturers - Specialty & Generic names. HLN ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COLL |
Collegium Pharmaceutical, Inc
|
1,405,567 | $50,881,525 | |
| 2 | PBH |
Prestige Consumer Healthcare Inc.
|
629,836 | $29,772,346 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
431,324 | $27,583,169 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
102,414 | $17,260,854 | |
| 5 | HLN |
Haleon plc
This page
|
957,121 | $8,929,938 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
475,589 | $6,891,283 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
144,366 | $5,923,336 | |
| 8 | ZTS |
Zoetis Inc.
|
18,655 | $1,340,547 |
All Filings in HLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,929,938 | 957,121 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $7,961,983 | 795,403 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,754,359 | 766,999 | Shares | Sole | 2026-01-22 | |
| No filing history on record for this holder in this stock. | ||||||